REG - Caspian Sunrise plc - Total Voting Rights

Caspian SunriseAnnouncement

18/08/2021 12:05

RNS Number : 0534J
  
Caspian Sunrise plc
  
18 August 2021
  
 

 
Caspian Sunrise PLC
("Caspian Sunrise" or the "Company")
 
Total Voting Rights
 
 
 
In respect to the share issue announced on 6 August 2021 the Company confirms that, 19,534,214 shares admitted to trading on 13 August 2021 and the remaining 450 shares will admit to trading on 19 August 2021.
 
Following the admission of the 19,534,664 new shares the total number of ordinary shares in issue will be 2,110,772,114, this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the DTRs.
 
Contacts:
 
Caspian Sunrise PLC
 
Clive Carver
Chairman                                                                                +7 727 375 0202
 
WH Ireland, Nominated Adviser & Broker
 
James Joyce                                                                            +44 (0) 207 220 1666
James Sinclair-Ford
 
Qualified person
 
Mr. Asslybek Umbetov, a member Association of Petroleum Engineers, has reviewed and approved the technical disclosures in this announcement.
 
This announcement has been posted to:
www.caspiansunrise.com/investors
 
The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
TVREAEPPFSNFEFA